Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 10, Issue 11, 2004, Pages 1547-1550

  Tangkijvanich, Pisit ^a   Mahachai, Varocha ^a   Suwangool, Pongspeera ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BILIRUBIN; CHLOROTRIANISENE;

ADULT; ADVANCED CANCER; ALCOHOL ABUSE; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; TUMOR VOLUME; ULTRASOUND;

EID: 2942752357     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i11.1547     Document Type: Article

References (25)

1. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risks factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: S290-308
2. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
3. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 225-236
4. Srivatanakul P. Epidemiology of liver cancer in Thailand. Asian Pac J Cancer Prev 2001; 2: 117-121
5. Tangkijvanich P, Hirsch P, Theamboonlers A, Nuchprayoon I, Poovorawan Y. Association of hepatitis viruses to hepatocellular carcinoma in Thailand. J Gastroenterol 1999; 34: 227-233
6. Lai CL, Gregory PB, Wu PC, Lok AS, Wong KP, Ng MM. Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance. Cancer 1987; 60: 1107-1110
7. Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R, Rodes J. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 1990; 12: 753-760
8. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1988; 48: 7314-7318
9. Nagasue N, Galizia G, Yukaya H, Kohno H, Chang YC, Hayashi T, Nakamura T. Better survival in women than in men after radical resection of hepatocellular carcinoma. Hepatogastroenterology 1989; 36: 379-383
10. Cong WM, Wu MC, Zhang XH, Chen H, Yuan JY. Primary hepatocellular carcinoma in women of Mainland China. A clinicopathologic analysis of 104 patients. Cancer 1993; 71: 2941-2945
11. Ng IO, Ng MM, Lai EC, Fan ST. Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach. Cancer 1995; 75: 18-22
12. Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hshia Y, Wu CW. Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma. Hepatogastroenterology 2000; 47: 466-469
13. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Longer survival in female than in male with hepatocellular carcinoma. J Gastroenterol Hepatol 2003; 18: 267-272
14. Trevisani F, Caraceni P, Bernardi M, D'Intino PE, Arienti V, Amorati P, Stefanin GF, Grazi G, Mazziotti A, Fornale L. Gross pathological types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental and clinical factors. Cancer 1993; 72: 1557-1563
15. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35(5 Suppl 2): S72-78
16. Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito T, Tamai S, Hoshino H, Okamoto N, Iimori K. The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer 1993; 72: 369-374
17. Matsumoto T, Takagi H, Mori M. Androgen dependency of hepatocarcinogenesis in TGF alpha transgenic mice. Liver 2000; 20: 228-233
18. Adami HO, Hsing AW, McLaughlin JK, Trichopoulos D, Hacker D, Ekbom A, Perrson I. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer 1992; 51: 898-902
19. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterolgy 2002; 122: 1609-1619
20. Qian J, Feng GS, Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol 2003; 9: 1885-1891
21. Pawarode A, Tangkijvanich P, Voravud N. Outcome of primary hepatocellular carcinoma treatment: an 8-year experience with 368 patients in Thailand. J Gastroenterol Hepatol 2000; 15: 860-864
22. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodal chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171
23. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270-285
24. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T, Yukaya H. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-494
25. Ng IO, Lai EC, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992; 70: 690-693